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The hyper-immunoglobulin M (HIGM) syndrome is a heterogeneous group 
of genetic disorders characterized by recurrent infections, decreased serum levels 
of immunoglobulin G (IgG) and IgA, and normal/increased serum levels of IgM. 
Herein, we describe three Turkish siblings with HIGM syndrome who had a ho-
mozygous missense mutation (c.70C>T, p.Arg24Trp) in the activation-induced cyti-
dine deaminase gene which results in autosomal recessive HIGM syndrome. Two of 
the siblings, sibling 1 and sibling 3, presented with cervical deep abscess and cervi-
cal tuberculosis lymphadenitis, respectively.
Keywords: hyper-immunoglobulin M syndrome, activation-induced cyti-
dine deaminase gene, tuberculosis lymphadenitis
Introduction
Patients with hyper-immunoglobulin M (HIGM) syndrome incline to re-
current infections, lymphoid hyperplasia, autoimmune, and infl ammatory disor-
ders. This syndrome can be inherited as X-linked, autosomal recessive (AR), or 
occasionally dominant mutations (AD). The main defect results from mutations 
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in the B-cell signaling genes, which are required for class switch recombination 
(CSR) and somatic hypermutation (SHM) [1]. At least six molecular defects as-
sociated with X-linked (CD40 ligand and the nuclear factor κB essential modula-
tor (NEMO genes), AR [CD40, activation-induced cytidine deaminase (AID) / or 
as known activation-induced cytidine deaminase (AICDA), uracil-DNA glycosy-
lase (UNG) genes], and AD [inhibitor of NF-B (IκBα) gene] have been reported 
as causing HIGM syndrome [2]. The AID gene mutations are the most frequent 
causative aberration in the AR HIGM patients. Defective gene product, AID pro-
tein, leads to the impairment of CSR and SHM generation [3–4]. More than 40 
different mutations have been identifi ed in the AID gene in patients with HIGM 
syndrome [5]. Herein, we report three Turkish siblings who had a homozygous 
missense mutation in AID gene. One of them, sibling 1, presented with cervical 
deep abscess. The other one, sibling 3, presented with cervical tuberculosis lym-
phadenitis.
Clinical Reports
In this study, we describe three siblings (two males, one female). There was 
second degree consanguinity between parents. The laboratory fi ndings (elevated 
IgM, decreased IgG and IgA) were consistent with HIGM syndrome. A homozy-
gous missense mutation (c.70C>T, p.Arg24Trp) was found in exon 2 in the AID 
gene. After the genetic diagnosis, hematopoietic stem cell transplantation (HSCT) 
was planned for the patients (Table I).
Sibling 1
An 11-year-old girl was admitted with left cervical mass to the Department 
of Pediatric Emergency Unit. Physical examination revealed 3×3 cm fl uctuated, 
hyperemic, mobile, and painful mass in left sternocleidomastoid muscle (SCM) 
posterolateral region. Also, she had cervical, bilateral inguinal multiple millimet-
ric mobile lymphadenopathies, and enlarged tonsils. Her growth parameters were 
normal. Cervical ultrasound showed 14×40×42 mm lobulated mass which is con-
sistent with abscess in left supraclavicular area and multiple cervical lymphade-
nopathies (Fig. 1). Staphylococcus aureus was cultured from the drained abscess 
material. Tbc was investigated because of her brother experienced Tbc lymphad-
enitis. The results of draining materials for tuberculosis were negative. No acid-
fast bacilli were seen nor cultured, Tbc polymerase chain reaction (PCR) and 
PPD were negative. Clinical improvement was observed with cefazolin and IVIG 
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therapy in two weeks. It was learned from the anamnesis, her medical problems 
started at 4 years of age with recurrent otitis, sinusitis, and pneumonia. She was 
treated lots of antibiotics cures. She was interned three times due to pneumonia. 
In her last two years of life, she experienced two times recurrent cervical painful 
mass which was spontaneously draining as in presented to our clinic. After ge-
netic diagnosis AR HIGM syndrome, monthly IVIG infusion and the trimetho-
prim-sulfamethoxazole (TMP-SMX) prophylaxis for Pneumocystis jiroveci 
pneumonia (PcP) was stared.
Sibling 2
Second sibling was an 8-year-old boy. His problems started at 3 years of 
age with recurrent upper respiratory infections such as otitis media and sinusitis. 
He underwent tonsillo-adenoidectomy when he was 5 years old due to recurrent 
otitis media. Also he had frequent courses of treatments with antibiotics as in 
other siblings. The same prophylaxis regimen (monthly IVIG and TMP-SMX for 
PcP) was initiated as in sibling 1.
Figure 1. Cervical deep abscess in patient 1
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Sibling 3
A 7-year-old boy was referred to the Department of Pediatric Immunology 
because of further diagnostic work-up with the other siblings. His medical prob-
lems started at 2 years of age with recurrent upper respiratory tract infections. At 
the age of 5 years, he was admitted to hospital with cervical mass. Physical ex-
amination revealed an anterior cervical 3×2 cm fl uctuated, painful mass and 
 cervical multiple millimetric lymphadenopathies. Cervical ultrasound showed 
34×18 mm lobulated heterogenic abscess formation mass in left submandibular 
area and 20×17×30 mm in view of the heterogeneous solid mass (conglomerated 
lymphadenopathy) in anterior left SCM region and multiple millimetric cervical 
lymphadenopathies. Histopathologic examination showed chronic non-caseating 
granulomatous infl ammation in the cervical mass biopsy. Acid-fast bacilli were 
seen. Also, Tbc was cultured from the biopsy material with BACTEC automated 
system. It was learned that the family lives with the grandfather who experienced 
lung Tbc disease 5 years ago. He had been treated with anti-tuberculosis treat-
ment for one year. Clinical improvement was seen with triple antituberculosis 
treatment in one year (Fig. 2). Also, the same prophylaxis regimen (monthly IVIG 
and TMP-SMX for PcP) was stared to the patient.
Figure 2. Sequelae of tuberculous lymphadenitis in patient 3
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Discussion
X-linked HIGM syndrome is the most common form of HIGM, which is 
caused by mutations in CD40L and NEMO genes, presents recurrent infections 
such as PcP and Cryptosporidium infections [6]. The AID gene encodes AID 
protein consists of 198 amino acids. In SHM and CSR, the role of AID gene has 
not yet been clearly elucidated. For this, in the medical literature, two molecular 
mechanisms have been presumed as DNA deamination and RNA-editing hypo-
tesis [7–9]. Patients with AR HIGM syndrome usually have normal B lympho-
cyte counts as in the presented patients. However, in contrast to the X linked 
patients, B cells are not able to switch from IgM secreting cells to the IgG, IgA, 
and IgE secreting cells even though CD40 antibody in the patients with AR 
HIGM syndrome. Namely in the patients with AR HIGM syndrome, there is a 
really intrinsic B cell abnormality. Patients with AR HIGM syndrome usually 
have lymphoid hyperplasia, recurrent respiratory and gastrointestinal infections 
with bacterial agents. These patients usually do not have susceptibility to oppor-
tunistic infections such as PcP. Also, these patients less likely have neutropenia 
according to the X-linked patients with HIGM syndrome [10–11]. Neutropenia 
was not observed in the presented siblings. The AR HIGM syndrome results 
from the AID gene mutations might be complicated autoimmune and infl amma-
tory disorders including polyarthritis, autoimmune hepatitis, hemolytic anemia, 
immune thrombocytopenia [12]. In the presented patients, autoimmune manifes-
tation was not observed up to date. In patients with AR HIGM syndrome, also the 
diagnosis of HIGM may be delayed to after fi rst decade of life as in sibling 1. The 
high levels of IgM antibodies ensure effective protection against some infectious 
agents in the patients with AR HIGM syndrome [5]. Thus, infections are not 
enough frequent and severe as in the presented patients to reveal a suspicion of 
immunodefi ciency disease at early ages [10]. Likewise in the all presented sib-
lings, the diagnosis of the AR HIGM syndrome was identifi ed after the age of 5 
years. Patients with X-linked HIGM syndrome often present opportunistic infec-
tions such as PcP, Cryptosporidium species, Toxoplasma gondii, and Mycobacte-
ria species. Almost 40% of opportunistic infections results from PcP in the pa-
tients with HIGM syndrome [13]. Tbc has been reported as 9–28% in the patients 
with X linked HIGM syndrome [14–15]. In contrast to the patients with X linked 
HIGM syndrome, the patients with AR HIGM syndrome caused by mutations in 
AID gene do not have opportunistic infections. It has been explained with AR 
HIGM syndrome is a pure B-cell defi ciency disease [5]. In the medical literature, 
to our knowledge, Tbc infections have been reported in only one patient with AR 
HIGM as Tbc osteomyelitis [16]. In our patients, sibling 3 presented with Tbc 
lymphadenitis.
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As mentioned above, recurrent infections are mainly bacterial and  mostly 
are observed as pneumonia in the AID gene defi cient patients. In these patients, 
other sites of infection are the skin, lymph nodes, gastrointestinal tract, and cen-
tral nervous system such as meningitis and encephalitis [3, 12]. In the medical 
literature, also, infections as abscess formation have been reported in only X-
linked HIGM patients [11, 17]. To our knowledge, deep abscess have been re-
ported rarely in the patients with AR HIGM syndrome [16]. Sibling 1 presented 
with recurrent cervical deep abscess.
In conclusion, AID gene defi cient patients have an increased risk of recur-
rent, severe infections leading to chronic sinopulmonary infections such as si-
nusitis, bronchiectasis, and lymphoid hyperplasia. Also, autoimmune and infl am-
matory disorders can be observed in the follow up of patients with AR HIGM 
syndrome. In addition to these informations, in the presented sibling 1 and 3, re-
current deep cervical abscess and cervical Tbc lymphadenitis were observed, 
respectively.
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